Tuesday, October 17, 2017 1:14:19 PM
1 hour ago - [color=red]ACQUIREMEDIA
As of 17 Oct 2017 at 12:51 PM EDT[img][/img]
Families Of Americans Killed And Injured By Iranian-Backed Iraqi Militia Sue Medical Companies For Allegedly Engaging In A Continuing Bribery Scheme That Supports Terrorism
WASHINGTON, Oct. 17, 2017 /PRNewswire/ -- A group of American veterans and civilians, and their families, filed a lawsuit against five major pharmaceutical and medical-supply corporations in federal court today, accusing the companies of knowingly or recklessly supporting an Iraqi terrorist group that attacked, killed, and wounded thousands of Americans in Iraq. Financing of this group allegedly has come via a longstanding and continuing bribery scheme that many of the defendants have pursued for years and was designed to keep their profits high.
The defendants being sued are the parent companies and/or subsidiaries of AstraZeneca plc (AZN), General Electric Company (GE), Johnson & Johnson (JNJ), Pfizer Inc. (PFE), and Roche Holding AG (RHHBY).
The defendants are being sued under the Anti-Terrorism Act by more than 100 Americans who were attacked or who had a family member attacked by the terrorist group Jaysh al-Mahdi (also known as JAM or the Mahdi Army).
Jaysh al-Mahdi is led by Muqtada al-Sadr, a notorious Iraqi cleric known for his fiery anti-American sermons and brutal attacks on Americans serving in Iraq after the fall of Saddam. As alleged in the complaint, Jaysh al-Mahdi has carried out its campaign of terror in Iraq using money and material provided directly by the defendants.
The suit follows an extensive investigation by the Washington, D.C.-based law firms of Sparacino & Andreson PLLC and Kellogg, Hansen, Todd, Figel & Frederick, PLLC.
"While Americans worked to rebuild Iraq, many were attacked by a terrorist group that we allege has been funded in part by the defendants' corrupt sales practices," said Josh Branson, a partner at Kellogg Hansen. "This lawsuit alleges that the defendants have aided and abetted terrorism in Iraq by paying bribes to the terrorists who ran the Iraqi Ministry of Health. We allege that those corrupt payments, including cash and free goods, provided an important source of financing for the terrorists."
Jaysh al-Mahdi is effectively the Iraqi franchise of Hezbollah, a Lebanese terrorist organization, and serves as Iran's terrorist proxy in Iraq. The complaint alleges that Jaysh al-Mahdi's terrorist attacks against Americans in Iraq have been planned, authorized, and sometimes conducted by Hezbollah.
"As alleged, many of the defendants have a documented history of paying bribes that supported terrorism under Saddam," said Ryan Sparacino, a partner at Sparacino & Andreson. "We believe that the evidence will show that when Jaysh al-Mahdi seized the Iraqi Health Ministry, the defendants continued paying the same bribes that many of them provided under Saddam – except in far greater amounts. The complaint alleges that these corruption schemes are extensive and ongoing. The lives of the families of those killed and injured have been forever changed, and the results have been devastating."
Kellogg Hansen and Sparacino & Andreson conducted an extensive investigation before filing the complaint. The firms spent thousands of hours working on the matter and analyzing hundreds of transactions between the defendants and the Iraqi Health Ministry. For many of the survivors of these attacks and the families of those killed, much of what the investigation uncovered came as a shock.
"My hope is that we can get justice for my brother's death and for so many others who didn't have to die in Iraq," said Ami Neiberger-Miller, the surviving sister of U.S. Army Specialist Christopher Neiberger, who was killed in action in Baghdad, Iraq on August 6, 2007, three days after his 22nd birthday.
The complaint is available at http://www.terrorismcase.com.
View original content:http://www.prnewswire.com/news-releases/families-of-americans-killed-and-injured-by-iranian-backed-iraqi-militia-sue-medical-companies-for-allegedly-engaging-in-a-continuing-bribery-scheme-that-supports-terrorism-300538096.html
SOURCE Sparacino & Andreson PLLC
Recent AUPH News
- Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference • Business Wire • 09/13/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 08:08:25 PM
- Aurinia Announces Board Restructuring • Business Wire • 09/12/2024 08:05:00 PM
- Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial • Business Wire • 09/05/2024 10:00:00 AM
- Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference • Business Wire • 08/28/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:06:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 10:07:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 10:03:38 AM
- Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results • Business Wire • 08/01/2024 10:00:00 AM
- Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024 • Business Wire • 07/19/2024 10:00:00 AM
- Aurinia to Participate in Upcoming Investor Healthcare Conferences • Business Wire • 07/02/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 09:25:28 PM
- Aurinia Announces 2024 Annual General Meeting Results • Business Wire • 06/14/2024 04:16:00 PM
- Aurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024 • Business Wire • 06/05/2024 10:00:00 AM
- Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce • Business Wire • 06/04/2024 09:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/04/2024 09:25:39 PM
- Aurinia Provides Update on Proxy Statement • Business Wire • 06/03/2024 10:30:00 PM
- Aurinia Will Attend 2024 Jefferies Global Healthcare Conference • Business Wire • 05/30/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:16:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:14:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:11:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:09:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:07:15 PM
- Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation’s Spring Clinical Meeting 2024 • Business Wire • 05/14/2024 10:00:00 AM
- Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024 • Business Wire • 05/09/2024 10:00:00 AM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM